Related references
Note: Only part of the references are listed.Influenza B Lineage Circulation and Hospitalization Rates in a Subtropical City, Hong Kong, 2000-2010
Paul K. S. Chan et al.
CLINICAL INFECTIOUS DISEASES (2013)
Effectiveness of Seasonal Influenza Vaccines in the United States During a Season With Circulation of All Three Vaccine Strains
John J. Treanor et al.
CLINICAL INFECTIOUS DISEASES (2012)
Improving the Estimation of Influenza-Related Mortality Over a Seasonal Baseline
Edward Goldstein et al.
EPIDEMIOLOGY (2012)
Excess Mortality Associated With Influenza A and B Virus in Hong Kong, 1998-2009
Peng Wu et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
The economic value of a quadrivalent versus trivalent influenza vaccine
Bruce Y. Lee et al.
VACCINE (2012)
Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine
Carrie Reed et al.
VACCINE (2012)
Complications and Outcomes of Pandemic 2009 Influenza A (H1N1) Virus Infection in Hospitalized Adults: How Do They Differ From Those in Seasonal Influenza?
Nelson Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Efficacy Studies of Influenza Vaccines: Effect of End Points Used and Characteristics of Vaccine Failures
Joshua G. Petrie et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Effectiveness of Seasonal Vaccine in Preventing Confirmed Influenza-Associated Hospitalizations in Community Dwelling Older Adults
H. Keipp Talbot et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Comparison of influenza vaccine effectiveness using different methods of case detection: Clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR)
Laura A. Coleman et al.
VACCINE (2011)
Clinical Efficacy of Cell Culture-Derived and Egg-Derived Inactivated Subunit Influenza Vaccines in Healthy Adults
Sharon Frey et al.
CLINICAL INFECTIOUS DISEASES (2010)
Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States
Sandra E. Talbird et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2009)
Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities
J. H. S. You et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2009)
Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004-2005 Season to the 2006-2007 Season
Edward A. Belongia et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines
Arnold S. Monto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines
Suzanne E. Ohmit et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Post-exposure influenza prophylaxis with oseltamivir - Cost effectiveness and cost utility in families in the UK
B Sander et al.
PHARMACOECONOMICS (2006)
Management of influenza symptoms in healthy adults - Cost-effectiveness of rapid testing and antiviral therapy
MB Rothberg et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2003)
Cost-effectiveness of newer treatment strategies for influenza
KJ Smith et al.
AMERICAN JOURNAL OF MEDICINE (2002)
One thousand health-related quality-of-life estimates
TO Tengs et al.
MEDICAL CARE (2000)
Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in Australia
JA Mauskopf et al.
PHARMACOECONOMICS (2000)
Share Paper
